Kutatások, Publikációk

Berger JR, Houff S. Neurological complications of herpes simplex virus type 2 infection. Arch Neurol . May 2008; 65(5):596-600.

Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: An evidence-based review. Arch Intern Med . 2008 Jun 9;168(11):1137-1144.

Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol . 2007 Nov;57(5):737-63.

Gupta R, Warren T, Wald A. Genital herpes. Lancet . 2007;370:2127-2137.

Hollier LM, Wendel GD. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. Cochrane Database Syst Rev . 2008 Jan 23;(1):CD004946.

Martin ET, Krantz E, Gottlieb SL, Magaret AS, Langenberg A, Stanberry L, et al. A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Arch Intern Med . 2009 Jul 13;169(13):1233-40.

Tobian AA, Serwadda D, Quinn TC, Kigozi G, Gravitt PE, Laeyendecker O, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med . 2009 Mar 26;360(13):1298-309

Wilhelmus, K. R. Therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev . 2008 Jan 23(1): CD002898.

Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA . 2006 Aug 23;296(8):964-73.

Miller, C.S., Danaher, R.J., Jacob, R.J. Molecular aspects of herpes simplex virus latency, reactivation and recurrence. Crit Rev Oral Biol Med. 1998;9:541–562.

Benedetti, J., Corey, L., Ashley, R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med. 1994;121:847–854.

Ashley, R., Wald, A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev. 1999;12:1–8.

Whitley, R.J., Kimberlin, D.W., Roizman, B. Herpes simplex viruses. Clin Infect Dis. 1998;26:541–553 (quiz 554-5).

Blyth, W.A., Hill, T.J. Establishment, maintenance and control of herpes simplex virus (HSV-1) latency. in: B.T. Rouse, C. Lopez (Eds.) Immunobiology of herpes simplex virus infection. CRC Press, Boca Raton; 1984:9.

Roizman, B., Sears, A.E. An inquiry into the mechanism of herpes simplex virus latency. Annu Rev Microbiol. 1987;41:543–571.

Turner, R., Shehab, Z., Osborne, K., Hendley, J.O. Shedding and survival of herpes simplex virus from “fever blisters”. Pediatrics. 1982;70:547–549.

Corey, L., Spear, P.G. Infections with herpes simplex viruses (1). N Engl J Med. 1986;314:686–691.

Norval, M. Herpes simplex virus, sunlight and immunosuppression. Rev Med Microbiol. 1992;3:227–234.

Halford, W.P., Gebhardt, B.M., Carr, D.J. Mechanisms of herpes simplex virus type 1 reactivation. J Virol. 1996;70:5051–5060.

Esmann, J. The many challenges of facial herpes simplex virus infection. J Antimicrobiol Chem. 2001;47:17–27.

Ribes, J., Steele, A., Seabolt, J., Baker, D. Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient population. J Clin Microbiol. 2001;39:3321–3325.

Spruance, S.L. The natural history of recurrent oro-facial herpes simplex virus infection. Semin Dermatol. 1992;11:200–206.

Sacks, S.L., Wilson, B.R. Genital herpes: management issues for the next century. Antiviral Chem Chemother. 1997;8:45–50.

Smith, J.S., Robinson, N.J. Age-specific prevalence of infection with herpes simplex virus type 2 and 1: a global review. J Infect Dis. 2002;186:S3–S28.

Wheeler, C.E. The herpes simplex problem. J Am Acad Dermatol. 1988;18:163–168.

Brugha, R., Keersmaekers, K., Renton, A., Meheus, A. Genital herpes infection: a review. Int J Epidemiol. 1997;26:698–709.

Whitley, R.J., Gnann, J.W. The epidemiology and clinical manifestations of herpes simplex virus infections. in: B. Roizman, R.J. Whitley, C. Lopez (Eds.) The human herpesviruses. Raven Press, New York; 1993:69–105.

Glick, M. Clinical aspects of recurrent oral herpes simplex virus infection. Compendium. 2002;23:4–8.

Lafferty, W. The challenging epidemiology of HSV-1 and HSV-2 and implications for serological testing. Herpes. 2002;9:51–55.

Steben, M. Genital herpes simplex virus infection. Clin Obstet Gynecol. 2005;48:838–844.

Kinghorn, G.R. Genital herpes: natural history and treatment of acute episodes. J Med Virol. 1993;:33–38.

Fleming, D., McQuillan, G., Johnson, R., Nahmias, A., Aral, S., Lee, F. et al, Herpes simplex virus type 2 in the United States, 1976-1994. N Engl J Med. 1997;337:1105–1111.

Corey, L., Handsfield, H. Genital herpes and public health: addressing a global problem. JAMA. 2000;283:791–794.

Wald, A. Herpes simplex virus type 2 transmission: risk factors and virus shedding. Herpes. 2004;11:130A–137A.

Frenkel, L., Garratty, E., Shen, J., Wheeler, N., Clark, O., Bryson, Y. Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med. 1993;118:414–418.

Boucher, F., Yasukawa, L., Bronzan, R., Hensleigh, P., Arvin, A., Prober, C. A prospective evaluation of primary genital herpes simplex virus types 2 infections acquired during pregnancy. Pediatr Infect Dis J. 1990;9:499–504.

Corey, L. First-episode, recurrent, and asymptomatic herpes simplex infections. J Am Acad Dermatol. 1988;18:169–172.

Greenberg, M.S. Ulcerative, vesicular, and bullous lesions. in: M.S. Greenberg, M. Glick (Eds.) Burket’s oral medicine, diagnosis and treatment. 10th ed. BC Decker, Hamilton, Ontario; 2003:50–84.

Huber, M.A. Herpes simplex type-1 virus infection. Quintessence Int. 2003;34:453–467.

Marquis, A.R., Straus, S.E. Herpes simplex. in: T.B. Fitzpatrick, I.M. Freedberg, A.Z. Eisen, K. Wolff, K.K. Austen, L.A. Goldsmith et al, (Eds.) Fitzpatrick’s Dermatology in general medicine. 6th ed. McGraw-Hill, New York; 2003:2059–2070.

Lafferty, W.E., Coombs, R.W., Benedetti, J., Critchlow, C., Corey, L. Recurrences after oral and genital herpes simplex infection. Influence of site of infection and viral type. N Engl J Med. 1987;316:1444–1449.

Sacks, S., Griffiths, P., Corey, L., Cohen, C., Cunningham, A., Dusheiko, G. et al, HSV shedding. Antiviral Res. 2004;63:S19–S26.

Bader, C., Crumpacker, C.S., Schnipper, L.E., Ransil, B., Clark, J.E., Amdt, K. et al, The natural history of recurrent facial oral infection with herpes simplex virus. J Infect Dis. 1978;138:897–905.

Embil, J.A., Stephens, R.G., Manuel, F.R. Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents. Can Med Assoc J. 1975;113:627–630.

Eversole, L.R. Inflammatory diseases of the mucous membranes. Part 1. Viral and fungal infections. J Calif Dent Assoc. 1994;22:52–57.

Spruance, S.L., Overall, J.C., Kern, E.R., Krueger, G.G., Pliam, V., Miller, W. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med. 1977;297:69–75.

Allen P. Tea tree oil: the science behind the antimicrobial hype. Lancet. 2001;358(9289):1245.

Ames M. Herpes: Comprehensive treatment strategy. Int J Integra Med. 2000;2(5):6-9.

Anzivino E, Fioriti D, Mischitelli M, Bellizzi A, Barucca V, Chiarini F, Pietropaolo V. Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy, and prevention. Virol. 2009;6:40.

Beauman JG. Genital herpes: a review. Am Fam Physician. 2005 Oct 15;72(8):1527-34. Review.

Carson CF, Ashton L, Dry L, Smith DW, Riley TV. Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis. J Antimicrob Chemother. 2001;48(3):450-1.

Fiore C, Eisenhut M, Krausse R, Ragazzi E, Pellati D, Armanini D, Bielenberg J. Antiviral effects of Glycyrrhiza species. Phytother Res. 2007 Sep 20; [Epub ahead of print].

Fried RG. Nonpharmacologic treatments in psychodermatology. Dermatol Clinics. 2002;20910;177-85.

Gaby AR. Natural remedies for Herpes simplex. Altern Med Rev. 2006 Jun;11(2):93-101. Review.

Godfrey HR, Godfrey NJ, Godfrey JC, Riley D. A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine. Altern Ther Health Med. 2001;7(3):49-56.

Gruzelier JH. A review of the impact of hypnosis, relaxation, guided imagery and individual differences on aspects of immunity and health. Stress. 2002;5(2):147-63.

Huleihel M, Isanu V. Anti-herpes simplex virus effect of an aqueous extract of propolis. Isr Med Assoc J. 2002;4(11 Suppl):923-7.

Jakob NJ, Lenhard T, Schnitzler P, et al. Herpes simplex virus enephalitis despite normal cell count in the cerebrospinal fluid. Crit Care Med. 2012;40(4):1304-8.

Jenaer M, Henry MF, Garcia A, Marichal B. Evaluation of 2LHERP in preventing recurrences of genital herpes. Institut International 3IDI. Br Homeopath J. 2000;89(4):174-7.

Koch C, Reichling J, Schneele J, Schnitzler P. Inhibitory effect of essential oils against herpes simplex virus type 2. Phytomedicine. 2007 Oct 30; [Epub ahead of print].

Lin K. Transmission of Herpes Simplex Virus via Oral Sex. American Family Physician. 2006;73(7).

L-lysine. Monograph. Altern Med Rev. 2007 Jun;12(2):169-72.

Marcason W. Will taking the amino acid supplement lysine prevent or treat the herpes simplex virus? J Am Diet Assoc. 2003;103(3):351.

Okuku HS, Sanders EJ, Nyiro J, et al. Factors associated with herpes simplex virus type 2 incidence in a cohort of human immunodeficiency virus type 1-seronegative Kenyan men and women reporting high-risk sexual behavior. Sex Transm Dis. 2011;38(9):837-44.

Patel P, Bush T, Mayer KH, et al. Prevalence and risk factors associated with herpes simplex virus-2 infection in a contemporary cohort of HIV-infected persons in the United States. Sex Transm Dis. 2012;39(2):154-60.

Pinninti S, Kimberlin D. Neonatal Herpes Simplex Virus Infection. Pediatric Clinics of North America. Philadelphia, PA: W.B. Saunders Company. 2013;60(2).

Rotblatt M, Ziment I. Evidence-Based Herbal Medicine. Philadelphia, PA: Hanley & Belfus, Inc; 2002:249-51.

Schnitzler P, Schon K, Reichling J. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture. Pharmazie. 2001;56(4):343-7.

Singh BB, Udani J, Vinjamury Sp, et al. Safety and effectiveness of an L-lysine, zinc, and herbal-based product on the treatment of facial and circumoral herpes. Altern Med Rev. 2005;10:123-7.

Sudenga SL, Kempf MC, McGwin G, Wilson CM, Hook EW, Shrestha S. Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents. Sex Transm Dis. 2012;39(4):300-5.

Tomblin FA Jr, Lucas KH. Lysine for management of herpes labialis. Am J Health Syst Pharm. 2001;58(4):298-300, 304.

Vynograd N, Vynograd I, Sosnowski Z. A comparative multi-centre study of the efficacy of propolis, acyclovir, and placebo in the treatment of genital herpes (HSV). Phytomedicine. 2000;7(1):1-6.

Fung MC, Bowen DL. Silver products for medical indications: risk-benefit assessment. Journal of Toxicology and Clinical Toxicology 34:119-26, 1996

Atherton P. Aloe vera revisited. Br J Phytother. 1998;4:76–83.

Shelton M. Aloe vera, its chemical and therapeutic properties. Int J Dermatol. 1991;30:679–83.

Atherton P. The essential Aloe vera: The actions and the evidence. 2nd ed 1997.

Syed TA, Afzal M, Ashfaq AS. Management of genital herpes in men with 0.5% Aloe vera extract in a hydrophilic cream A placebo-controlled double-blind study. J Derm Treatment. 1997;8:99–102.

Syed TA, Cheema KM, Ahmad SA, Ashfaq A. Aloe vera extract 0.5% in hydrophilic cream versus aloe vera gel for the measurement of genital herpes in males: A placebo-controlled, double-blind, comparative study. J Eur Acad Derm Venereol. 1996;7:294–5.

Marshall JM. Aloe vera gel: What is the evidence? Pharma Jr. 1990;24:360–2.

Li Y, Schellhorn HE. New developments and novel therapeutic perspectives for vitamin C. J Nutr 2007;137:2171-84.

Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr 1999;69:1086-107.

Wang AH, Still C. Old world meets modern: a case report of scurvy. Nutr Clin Pract 2007;22:445-8.

Gregory JF 3rd. Ascorbic acid bioavailability in foods and supplements. Nutr Rev 1993;51:301-3.

Heggers JP1, Cottingham J, Gusman J, Reagor L, McCoy L, Carino E, Cox R, Zhao JG. The effectiveness of processed grapefruit-seed extract as an antibacterial agent: II. Mechanism of action and in vitro toxicity. J Altern Complement Med. 2002 Jun;8(3):333-40.

Donald Goldberg, Arnold Gitomer, Robert Abel. The Best Supplements for Your Health. p.185.

Fung MC, Bowen DL. Silver products for medical indications: risk-benefit assessment. Journal of Toxicology and Clinical Toxicology 34:119-26, 1996.

Wickless SC, Schwader TA. Medical mystery—The answer. New England Journal of Medicine 352:2349-2350, 2004.

Gaby AR. Natural remedies for Herpes simplex. Altern Med Rev. 2006 Jun;11(2):93-101. Review.